Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial †
Titel:
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial †
Auteur:
Weinstein, C. Jordan, K. Green, S.A. Camacho, E. Khanani, S. Beckford-Brathwaite, E. Vallejos, W. Liang, L.W. Noga, S.J. Rapoport, B.L.